SELLAS Life Sciences (SLS) Enterprise Value (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Enterprise Value for 9 consecutive years, with -$100000.0 as the latest value for Q3 2024.
- Quarterly Enterprise Value rose 97.5% to -$100000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was -$100000.0 through Sep 2024, up 97.5% year-over-year, with the annual reading at -$2.5 million for FY2023, 85.23% up from the prior year.
- Enterprise Value for Q3 2024 was -$100000.0 at SELLAS Life Sciences, roughly flat from -$100000.0 in the prior quarter.
- The five-year high for Enterprise Value was -$100000.0 in Q1 2020, with the low at -$35.3 million in Q4 2020.
- Average Enterprise Value over 5 years is -$7.4 million, with a median of -$100000.0 recorded in 2020.
- The sharpest move saw Enterprise Value plummeted 35202.0% in 2020, then surged 99.64% in 2022.
- Over 5 years, Enterprise Value stood at -$35.3 million in 2020, then skyrocketed by 39.51% to -$21.4 million in 2021, then rose by 19.81% to -$17.1 million in 2022, then soared by 85.23% to -$2.5 million in 2023, then skyrocketed by 96.05% to -$100000.0 in 2024.
- According to Business Quant data, Enterprise Value over the past three periods came in at -$100000.0, -$100000.0, and -$100000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.